Saturday, June 27, 2026
VideoAdmin
NewsWhite
Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker
BUSINESS
Unverified

Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker

June 19, 2026·Source: CNBC·33 views

Share This Article

While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver

Share This Article

Originally reported by CNBC. Read the original article

Related Articles

Goldman says private credit may invest a lot of 'dry powder' in this sector
BUSINESS

Goldman says private credit may invest a lot of 'dry powder' in this sector

Private credit may use its sizable amount of "dry powder" to combat potential financing market dislocations in this sector, according to Goldman Sachs.

CNBC·23h ago
A $2.5 Billion Whodunit: The Hack That Dented the U.K. Economy
BUSINESS

A $2.5 Billion Whodunit: The Hack That Dented the U.K. Economy

A loose collective of cybercriminals initially took credit for crippling Jaguar Land Rover last year. Investigators now see Russian hands behind the ransomware attack.

NY Times·1d ago
Ariel’s John Rogers likes these small-cap names as the market rally broadens
BUSINESS

Ariel’s John Rogers likes these small-cap names as the market rally broadens

Ariel Investments' John Rogers highlighted for-profit education company Covista as a small-cap stock he's currently bullish on.

CNBC·1d ago
Polymarket says hackers stole users’ funds
BUSINESS

Polymarket says hackers stole users’ funds

The prediction market giant Polymarket said it's refunding users who had funds stolen due to a third-party breach.

TechCrunch·1d ago